Topica nails down $27 million Series B in pursuit of fungal infection treatment
20 October 2011
Donna Young
Please Login to read the full article.
20 October 2011
Donna Young
donna.young@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Stellar, Apricus form deal for nail fungus drug in Canada
- Disappointment for Moberg in Phase II onychomycosis trial
- Anacor, GSK revise R&D pact on boron-containing anti-infective drug candidates
- MMV ups funding under deal with Anacor to allow Phase I trial of malaria candidate
COMMENT
Other Informa Comment
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
